Circassia Pharmaceuticals (GB:NIOX) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Circassia Pharmaceuticals, known as NIOX Group plc, has announced the launch of its 2024 Save As You Earn (SAYE) Scheme, allowing all eligible UK employees to purchase company shares at a 20% discount. A total of 133,762 options were granted, with key executives Ian Johnson and Michael Roller receiving 36,152 options each. The option exercise price is set at 51.31 pence per share, which is notably lower than the recent average mid-market closing price.
For further insights into GB:NIOX stock, check out TipRanks’ Stock Analysis page.